Zobrazeno 1 - 10 of 80 pro vyhledávání: '"AlJedai A"'
1
Akademický článek
Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation : Natural history and predictors of outcome.
Autor: Mudawi Hatim, Helmy Ahmed, Kamel Yasser, Al Saghier Mohammed, Al Sofayan Mohammed, Al Sebayel Mohammed, Khalaf Hatem, Al Bahili Hamad, Al Shiek Yasser, Alawi Khalil, AlJedai Ahmed, Mohamed Hazem, Al Hamoudi Waleed, Abdo Ayman
Publikováno v: Annals of Saudi Medicine, Vol 29, Iss 2, Pp 91-97 (2009)
Background and Objectives: There are few reports on hepatitis C virus genotype 4 (HCV-4) recurrences after orthotopic liver transplantation (OLT). Therefore, we undertook a study to determine the epidemiological, clinical and virological characterist
Externí odkaz: https://doaj.org/article/2e00a16e2ed94a30b428aeeae6f83d09
Zobrazit plný text záznamu
2
Akademický článek
The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
Autor: Ghazwa B. Korayem, Ohoud Aljuhani, Ali F. Altebainawi, Abdulrahman I. Al Shaya, Lina I. Alnajjar, Abdulrahman Alissa, Mohammed Aldhaeefi, Raed Kensara, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Omar Alhuthaili, Ramesh Vishwakarma, Namareq Aldardeer, Khalid Eljaaly, Aisha Alharbi, Shmeylan Al Harbi, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy, Ahmed Aljedai, Khalid Al Sulaiman
Publikováno v: International Journal of Infectious Diseases, Vol 122, Iss , Pp 252-259 (2022)
ABSTRACT: Objectives: Evidence supports tocilizumab (TCZ) benefit and safety in adult patients with severe COVID-19. However, its effectiveness in critically ill older adult patients remains questionable. Thus, the study aimed to evaluate the safety
Externí odkaz: https://doaj.org/article/145f3c9134124608801970a63d78ac89
Zobrazit plný text záznamu
4
Akademický článek
Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial
Autor: Aziza Ajlan, Hassan Aleid, Tariq Zulfiquar Ali, Hala Joharji, Khalid Almeshari, Ahmed Mohammed Nazmi, Yaser Shah, Edward Devol, Dalal Alkortas, Zinah Alabdulkarim, Dieter Broering, Ibrahim Alahmadi, Asad Ullah, Anwar Alotaibi, Ahmed Aljedai
Publikováno v: Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Induction therapy with IL-2 receptor antagonist (IL2-RA) is recommended as a first-line agent in low immunological risk kidney transplant recipients. However, the role of IL2-RA in the setting of tacrolimus-based immunosuppression
Externí odkaz: https://doaj.org/article/d3ec14f2b3d74cc0804fcd95bb2bbc9e
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje